Meitav Investment House’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143M Buy
+119,333
New +$122M 0.96% 27
2024
Q1
– Sell
-21,506
Closed -$12.5M – 303
2023
Q4
$12.5M Hold
21,506
– – 0.18% 94
2023
Q3
$11.8M Sell
21,506
-130
-0.6% -$67K 0.19% 93
2023
Q2
$10M Sell
21,636
-356
-2% -$149K 0.16% 101
2023
Q1
$8.77M Sell
21,992
-462
-2% -$156K 0.15% 114
2022
Q4
$8.27M Sell
22,454
-4,917
-18% -$1.74M 0.14% 119
2022
Q3
$9.03M Hold
27,371
– – 0.16% 107
2022
Q2
$8.87M Buy
27,371
+16,539
+153% +$4.96M 0.15% 115
2022
Q1
$3.1M Sell
10,832
-120
-1% -$30.9K 0.05% 187
2021
Q4
$3.02M Buy
10,952
+155
+1% +$39.3K 0.05% 186
2021
Q3
$2.5M Hold
10,797
– – 0.04% 193
2021
Q2
$2.48M Hold
10,797
– – 0.06% 162
2021
Q1
$2.02M Buy
+10,797
New +$2.11M 0.06% 162

Other funds holding LLY

Meitav Investment House's LLY Position: Q2 2026 in Review

Meitav Investment House opened a new position in Eli Lilly (LLY) in Q2 2026: 119,333 shares worth $143M. The stake represents 0.96% of the portfolio and ranks #27 among its holdings. This is a return to the name: Meitav Investment House previously reported a position in LLY as recently as Q4 2023.

Meitav Investment House first reported a position in LLY in Q1 2021 and has held it in 13 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Meitav Investment House held 119,333 shares of Eli Lilly worth $143M as of Q2 2026.
  • Eli Lilly was a new Meitav Investment House position in Q2 2026.
  • Eli Lilly made up 0.96% of Meitav Investment House's portfolio in Q2 2026, its #27 holding.
  • Meitav Investment House first reported a position in Eli Lilly in Q1 2021 and has held it in 13 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Meitav Investment House's 13F filing for Q2 2026, filed 20 Jul 2026.